Search Results - "Beer, Kenneth"

Comparison of the Rheological Properties of Viscosity and Elasticity in Two Categories of Soft Tissue Fillers: Calcium Hydroxylapatite and Hyaluronic Acid by SUNDARAM, HEMA, VOIGTS, BOB, BEER, KENNETH, MELAND, MELISSA

“…BACKGROUND Two types of soft tissue filler that are in common use are those formulated primarily with calcium hydroxylapatite (CaHA) and those with…”
Get full text

Commentary on a Simple Elastomer-Pad Vibratory Dampener to Maximize Pain Control of Injections in Patientsʼ Undergoing Dermatological Surgery by Beer, Kenneth R

Get full text

Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program by Cohen, Joel L., Green, Lawrence J., Beer, Kenneth R., Liu, Yan, Gallagher, Conor J.

“…Pivotal studies of approved botulinum toxin type A (BoNTA) formulations for treatment of glabellar lines have mostly included treatment-naive participants, and…”
Get full text

Safety and effectiveness of injection of calcium hydroxylapatite via blunt cannula compared to injection by needle for correction of nasolabial folds by Beer, Kenneth R

“…Summary Background Pain and potential adverse events (AE) remain challenges for patients being treated with calcium hydroxylapatite (CaHA; Radiesse),…”
Get full text

PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study data by Cox, Sue Ellen, Ascher, Benjamin, Avelar, Rui L., Beer, Kenneth R., Carruthers, Jean, Cartier, Hugues, Fagien, Steven, Solish, Nowell

“…Background Despite the absence of Phase III clinical trial data to support their use, 3.4% of all neurotoxin treatments performed internationally for esthetic…”
Get full text

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles by Hanke, C. William, MD, Beer, Kenneth R., MD, Stockfleth, Eggert, MD, Wu, Jason, MD, Rosen, Theodore, MD, Levy, Sharon, MD

“…Background Imiquimod 5% cream is approved as a 16-week regimen for the treatment of actinic keratoses involving a 25-cm2 area of skin. Objective We sought to…”
Get full text

Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies by Beer, Kenneth R, Shamban, Ava Theresa, Avelar, Rui L, Gross, John E, Jonker, Anneke

“…BACKGROUNDPrabotulinumtoxinA is a 900-kDa botulinum toxin Type A produced by Clostridium botulinum. OBJECTIVETo investigate the efficacy and safety of…”
Get full text

Identification and Management of Mental Health Issues by Dermatologic Surgeons: A Survey of American Society for Dermatologic Surgery Members by Sarwer, David B, Spitzer, Jacqueline C, Sobanko, Joseph F, Beer, Kenneth R

“…BACKGROUNDDermatologists have long been interested in mental health issues of their patients. Some psychosocial distress likely motivates the pursuit of…”
Get full text

Treatment of Eyebrow Hypotrichosis Using Bimatoprost: A Randomized, Double‐Blind, Vehicle‐Controlled Pilot Study by Beer, Kenneth R., Julius, Hillary, Dunn, Monica, Wilson, Fred

“…Background The Food and Drug Administration has approved bimatoprost ophthalmic solution (0.03%) for the treatment of eyelash hypotrichosis. Previous reports…”
Get full text

Combined treatment for skin rejuvenation and soft-tissue augmentation of the aging face by Beer, Kenneth R

“…Multiple types of anti-aging treatments are required to address the various etiologies of facial aging. Soft-tissue augmentation provides a minimally invasive…”
Get more information

Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillers by Alam, Murad, Kakar, Rohit, Nodzenski, Michael, Ibrahim, Omer, Disphanurat, Wareeporn, Bolotin, Diana, Borovicka, Judy H, Pace, Natalie, Alster, Tina S, Arndt, Kenneth A, Beer, Kenneth R, Berlin, Joshua M, Bernstein, Leonard J, Brightman, Lori A, Butterwick, Kimberly, Cox, Sue Ellen, Chotzen, Vera, Fabi, Sabrina G, Fitzpatrick, Richard E, Geronemus, Roy G, Goldman, Mitchel P, Groff, William F, Kaminer, Michael S, Kilmer, Suzanne, Rohrer, Thomas E, Tanzi, Elizabeth L, Silva, Susan K, Yoo, Simon S, Weinkle, Susan H, Strasswimmer, John, Poon, Emily, Dover, Jeffrey S

“…Common noninvasive to minimally invasive cosmetic dermatologic procedures are widely believed to be safe given the low incidence of reported adverse events,…”
Get more information

Aesthetic treatment considerations for the eyebrows and periorbital complex by Beer, Kenneth R, Bayers, Stephanie, Beer, Jacob

“…The periorbital complex is a critical cosmetic unit. Treatments for this region range from topical prescriptions to enhance the brow hair to topical…”
Get more information

Dermal Fillers and Combinations of Fillers for Facial Rejuvenation by Beer, Kenneth, MD, PA

“…Until recently, the use of dermal fillers was limited in the United States by the small number of products approved by the Food and Drug Administration. The…”
Get full text

Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin by Beer, Kenneth R, Julius, Hillary, Dunn, Monica, Wilson, Fred

“…Summary Botulinum toxins are currently used to reduce facial muscle activity, and hyaluronic acid is used to correct volume loss. This study evaluates the…”
Get full text

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients by Lorenc, Z Paul, Adelglass, Jeffrey M, Avelar, Rui L, Baumann, Leslie, Beer, Kenneth R, Cohen, Joel L, Cox, Sue Ellen, Dayan, Steven H, Dover, Jeffrey S, Downie, Jeanine B, Draelos, Zoe Diana, Goldman, Mitchel P, Gross, John E, Joseph, John H, Kaufman-Janette, Joely, Moy, Ronald L, Nestor, Mark, Schlessinger, Joel, Smith, Stacy R, Weiss, Robert A

“…Abstract Background PrabotulinumtoxinA is a 900-kDa botulinum toxin type A produced by Clostridium botulinum. Objectives The authors sought to investigate the…”
Get full text

Skin Cooling Provides Minimal Relief of Patient Discomfort During Periocular Botulinum Toxin Type A Injection by BEER, KENNETH R., WILSON, FRED

“…The authors have indicated no significant interest with commercial supporters…”
Get full text

Comparative Evaluation of the Safety and Efficacy of Botulinum Toxin Type A and Topical Creams for Treating Moderate‐to‐Severe Glabellar Rhytids by BEER, KENNETH R.

“…BACKGROUND Several nonprescription products purport similar or better outcomes than botulinum toxin type A (Botox® Cosmetic) for treating wrinkles, but these…”
Get full text

Treatment of margin positive basal cell carcinoma with vismodegib: case report and consideration of treatment options and their implications by Bayers, Stephanie, Kapp, Daniel L, Beer, Kenneth R, Slavin, Benjamin

“…Historically, basal cell carcinomas (BCCs) that are neither surgically resectable nor candidates for radiation therapy have had few treatment options. The…”
Get more information

Advanced basal cell carcinoma: therapeutic options and considerations for patient care. Introduction by Beer, Kenneth R, Beer, Michael S

Get more information

Rapid onset of response and patient-reported outcomes after onabotulinumtoxinA treatment of moderate-to-severe glabellar lines by Beer, Kenneth R, Boyd, Charles, Patel, Rina K, Bowen, Beta, James, Steven P, Brin, Mitchell F

“…no previously published botulinum toxin type A cosmetic trials included both physician and subject measures of onset. determine physician- and subject-reported…”
Get more information